The relation between bone and stone formation

Calcified Tissue International

Volumn 93, Issue 4, 2013, Pages 374-381

  Krieger, Nancy S ^a   Bushinsky, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Bone density; Hypercalciuria; Nephrolithiasis

Indexed keywords

CALCIUM; CHLORTALIDONE; CITRATE POTASSIUM; HYDROCHLOROTHIAZIDE; THIAZIDE DIURETIC AGENT; VITAMIN D RECEPTOR;

ARTICLE; BONE DENSITY; BONE STRENGTH; BONE STRUCTURE; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CALCIUM STONE; CALCIUM TRANSPORT; CALCIUM URINE LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MECHANISM; FRACTURE; HUMAN; HYPERCALCIURIA; HYPERTENSION; IDIOPATHIC DISEASE; INTESTINE ABSORPTION; KIDNEY TUBULE ABSORPTION; NEPHROLITHIASIS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; TRABECULAR BONE;

ABSORPTION; ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CALCIUM; CALCIUM OXALATE; CALCIUM, DIETARY; DISEASE MODELS, ANIMAL; FEMALE; HOMEOSTASIS; HUMANS; HYPERCALCIURIA; KIDNEY CALCULI; KIDNEY TUBULES; MALE; NEPHROLITHIASIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL;

EID: 84886084677     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9686-2     Document Type: Article

References (94)

1. Monk RD, Bushinsky DA (2011) Kidney stones. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams textbook of endocrinology. WB Saunders, Philadelphia, pp 1350-1367
2. Bushinsky DA, Coe FL, Moe OW (2012) Nephrolithiasis. In: Brenner BM (ed) The kidney. WB Saunders, Philadelphia, pp 1455-1507
3. Worcester EM, Coe FL (2010) Calcium kidney stones. N Engl J Med 363:954-963
4. Bushinsky DA, Moe OW (2012) Calcium stones. In: De Broe ME (ed) Oxford textbook of clinical nephrology. Oxford University Press, Oxford
5. Bushinsky DA (2002) Recurrent hypercalciuric nephrolithiasis - does diet help? N Engl J Med 346:124-125 (Pubitemid 34438904)
6. Pak CYC (1992) Pathophysiology of calcium nephrolithiasis. In: Seldin DW, Giebisch G (eds) The kidney: physiology and pathophysiology. Raven Press, New York, pp 2461-2480
7. Asplin JR, Bauer KA, Kinder J, Muller G, Coe BJ, Parks JH, Coe FL (2003) Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 63:662-669 (Pubitemid 36126813)
8. Pacifici R, Rothstein M, Rifas L et al (1990) Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 71:138-145
9. Pietschmann F, Breslau NA, Pak CYC (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7:1383-1388 (Pubitemid 23007083)
10. Vezzoli G, Soldati L, Ardila M et al (2005) Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study. Kidney Int 67:2006-2014 (Pubitemid 40577739)
11. Giannini S, Nobile M, Dalle Carbonare L et al (2003) Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 149:209-213 (Pubitemid 37120993)
12. Jaeger P, Lippuner K, Casez JP, Hess B, Ackerman D, Hug C (1994) Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 9:1525-1532 (Pubitemid 24300101)
13. Giannini S, Nobile M, Sartori L, Calo L, Tasca A, Dalle Carbonare L, Ciuffreda M, D'Angelo A, Pagano F, Crepaldi G (1998) Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 50:94-100 (Pubitemid 28401001)
14. Misael da Silva AM, dos Reis LM, Pereira RC, Futata E, Branco-Martins CT, Noronha IL, Wajchemberg BL, Jorgetti V (2002) Bone involvement in idiopathic hypercalciuria. Clin Nephrol 57:183-191 (Pubitemid 34213656)
15. Tasca A, Cacciola A, Ferrarese P, Ioverno E, Visona E, Bernardi C, Nobile M, Giannini S (2002) Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology 59:865-869 (Pubitemid 34522177)
16. Heilberg IP, Weisinger JR (2006) Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 15:394-402 (Pubitemid 44297982)
17. Lauderdale DS, Thisted RA, Wen M, Favus M (2001) Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner 16:1893-1898 (Pubitemid 32911497)
18. Cauley JA, Blackwell T, Zmuda JM, Fullman RL, Ensrud KE, Stone KL, Barrett-Connor E, Orwoll ES (2010) Correlates of trabecular and cortical volumetric bone mineral density at the femoral neck and lumbar spine: the osteoporotic fractures in men study (MrOS). J Bone Miner Res 25:1958-1971
19. Urivetzky M, Anna PS, Smith AD (1988) Plasma osteocalcin levels in stone disease: a potential aid in the differential diagnosis of calcium nephrolithiasis. J Urol 139:12-14 (Pubitemid 18050726)
20. Liberman UA, Sperling O, Atsmon A, Frank M, Modan M, deVries A (1968) Metabolic and calcium kinetic studies in idiopathic hypercalciuria. J Clin Invest 47:2580-2590
21. Weisinger JR, Alonzo E, Bellorin-Font E et al (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244-250 (Pubitemid 26024239)
22. Ghazali A, Fuentes V, Desaint C et al (1997) Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82:32-38 (Pubitemid 27021266)
23. Steiniche T, Mosekilde L, Christensen MS, Melsen F (1989) Histomorphometric analysis of bone in idiopathic hypercalciuria before and after treatment with thiazide. APMIS 97:302-308 (Pubitemid 19142677)
24. Letavernier E, Traxer O, Daudon M, Tligui M, Hubert-Brierre J, Guerrot D, Sebag A, Baud L, Haymann JP (2011) Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. Clin J Am Soc Nephrol 6:1149-1154
25. Lemann J Jr, Bushinsky DA, Hamm LL (2003) Bone buffering of acid and base in humans. Am J Physiol Renal Physiol 285:F811-F832
26. Bushinsky DA, Frick KK, Nehrke K (2006) Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 15:403-418 (Pubitemid 44297983)
27. Bushinsky DA, Favus MJ (1988) Mechanism of hypercalciuria in genetic hypercalciuric rats: inherited defect in intestinal calcium transport. J Clin Invest 82:1585-1591 (Pubitemid 19007763)
28. Kim M, Sessler NE, Tembe V, Favus MJ, Bushinsky DA (1993) Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 43:189-196 (Pubitemid 23167465)
29. 3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 72:25-32 (Pubitemid 12090782)
30. Pak CY (1998) Kidney stones. Lancet 351:1797-1801 (Pubitemid 28269199)
31. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS (1999) Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55:234-243 (Pubitemid 29004255)
32. 3 in bone from genetic hypercalciuric rats. Am J Physiol Cell Physiol 271:C130-C135
33. Tsuruoka S, Bushinsky DA, Schwartz GJ (1997) Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 51:1540-1547 (Pubitemid 27239910)
34. 3 in genetic hypercalciuric stone forming rats. J Am Soc Nephrol 16:1300-1308 (Pubitemid 41716514)
35. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA, Favus MJ (2005) Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20:447-454 (Pubitemid 40293493)
36. Bai S, Wang H, Shen J, Zhou R, Bushinsky DA, Favus MJ (2010) Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail. J Bone Miner Res 25:830-840
37. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ (1993) Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest 91:661-667 (Pubitemid 23064152)
38. Larriba MJ, Bonilla F, Muñoz A (2010) The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression. J Steroid Biochem Mol Biol 121:106-109
39. Favus MJ, Karnauskas AJ, Parks JH, Coe FL (2004) Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 89:4937-4943 (Pubitemid 39391431)
40. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL (1995) Stone formation in genetic hypercalciuric rats. Kidney Int 48:1705-1713
41. Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL (1997) Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int 51:640-645 (Pubitemid 27157946)
42. Bushinsky DA, Parker WR, Asplin JR (2000) Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57:550-560 (Pubitemid 30430647)
43. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607-616 (Pubitemid 36278579)
44. Bushinsky DA (2003) Nephrolithiasis: site of the initial solid phase. J Clin Invest 111:602-605 (Pubitemid 36278578)
45. Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL (2002) Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61:975-987 (Pubitemid 34175466)
46. Grynpas M, Waldman S, Holmyard D, Bushinsky DA (2009) Genetic hypercalciuric stone-forming rats have a primary decrease in bone mineral density and strength. J Bone Miner Res 24:1420-1426
47. Friedman PA, Bushinsky DA (1999) Diuretic effects on calcium metabolism. Semin Nephrol 19:551-556 (Pubitemid 29518109)
48. Coe FL, Parks JH, Bushinsky DA, Langman CB, Favus MJ (1988) Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int 33:1140-1146
49. Bushinsky DA, Asplin JR (2005) Thiazides reduce brushite, but not calcium oxalate, supersaturation and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 16:417-424 (Pubitemid 41725137)
50. Breslau NA, Moses AM, Weiner IM (1976) The role of volume contraction in the hypocalciuric action of chlorothiazide. Kidney Int 10:164-170
51. Pearle MS, Roehrborn CG, Pak CYC (1999) Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13:679-685
52. Ernst ME, Carter BL, Zheng S, Grimm RH (2010) Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens 23:440-446
53. Renjmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167-175 (Pubitemid 41557145)
54. Feskanisch D, Willett WC, Stampfer JM, Golditz GA (1997) A prospective study of thiazide use and fractures in women. Osteoporos Int 7:79-84 (Pubitemid 27077792)
55. Sigurdsson G, Franzson L (2001) Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels. J Intern Med 250:51-56 (Pubitemid 34208938)
56. Vescini F, Buffa A, La Manna G, Ciavatti A, Rizzoli E, Bottura A, Stefoni S, Caudarella R (2005) Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers. J Endocrinol Invest 28:218-222 (Pubitemid 43162768)
57. Bushinsky DA, Willett T, Asplin JR, Culbertson C, Che SPY, Grynpas M (2011) Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats. J Bone Miner Res 26:1904-1912
58. Bushinsky DA, Favus MJ, Coe FL (1984) Mechanism of chronic hypocalciuria with chlorthalidone: reduced calcium absorption. Am J Physiol Renal Fluid Electrolyte Physiol 247:F746-F752
59. Hall TJ, Schaueblin M (1994) Hydrochlorothiazide inhibits osteoclastic bone resorption in vitro. Calcif Tissue Int 55:266-268 (Pubitemid 24292342)
60. Lalande A, Roux S, Denne MA, Stanley ER, Schiavi P, Guez D, De Vernejoul MC (2001) Indapamide, a thiazide-like diuretic, decreases bone resorption in vitro. J Bone Miner Res 16:361-370 (Pubitemid 32105417)
61. Barry EL, Gesek FA, Kaplan MR, Hebert SC, Friedman PA (1997) Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am J Physiol Cell Physiol 272:C109-C116
62. Aubin R, Menard P, Lajeunesse D (1996) Selective effect of thiazides on the human osteoblast-like cell line MG-63. Kidney Int 50:1476-1482 (Pubitemid 26364251)
63. 3 receptors. J Bone Miner Res 15:894-901 (Pubitemid 30233413)
64. Dvorak MM, De Joussineau C, Carter DH, Pisitkun T, Knepper MA, Gamba G, Kemp PJ, Riccardi D (2007) Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. J Am Soc Nephrol 18:2509-2516 (Pubitemid 47378867)
65. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63:1817-1823 (Pubitemid 36513328)
66. Sakhaee K, Maalouf NM, Sinnott B (2012) Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab 97:1847-1860
67. Sakhaee K, Maalouf NM, Kumar R, Pasch A, Moe OW (2011) Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 79:393-403
68. Trombetti A, Herrmann F, Hoffmeyer P, Schurch MA, Bonjour JP, Rizzoli R (2002) Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 13:731-737 (Pubitemid 35001001)
69. Asplin JR, Donahue SE, Lindeman C, Michalenka A, Strutz KL, Bushinsky DA (2009) Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol 20:1246-1253
70. Hoopes RR, Reid R, Sen S, Szpirer C, Dixon P, Pannet A, Thakker RV, Bushinsky DA, Scheinman SJ (2003) Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J Am Soc Nephrol 14:1844-1850 (Pubitemid 36750479)
71. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL (1994) Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int 45:58-65 (Pubitemid 24045992)
72. Bushinsky DA, LaPlante K, Asplin JR (2006) Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int 69:1586-1592
73. Coe FL, Favus MJ, Asplin JR (2004) Nephrolithiasis. In: Brenner BM, Rector FC Jr (eds) The kidney. WB Saunders, Philadelphia, pp 1819-1866
74. 3: a new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 101:2223-2232 (Pubitemid 28244106)
75. Pak CYC, Kaplan R, Bone H (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 292:497
76. Pak CYC, Britton F, Peterson R, Ward D, Northcutt C, Breslau NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman D, Peters P (1980) Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med 69:19-30 (Pubitemid 10084682)
77. Bataille P, Achard JM, Fournier A, Boudailliez B, Westell PF, Esper NE, Bergot C, Jans I, Lalau JD, Petit J, Henon G, Jeantet MAL, Bouillon R, Sebert JL (1991) Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 39:1193-1205
78. Shen FH, Baylink DJ, Nielsen RL, Sherrard DJ, Ivey JL, Haussler MR (1977) Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. J Lab Clin Med 90:955-962 (Pubitemid 8235968)
79. Coe FL, Canterbury JM, Firpo JJ, Reiss E (1973) Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest 52:134-142
80. Burckhardt P, Jaeger P (1981) Secondary hyperparathyroidism in idiopathic renal hypercalciuria: fact or theory? J Clin Endocrinol Metab 55:550
81. Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC (1977) The role of 1,25 dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59:756-760 (Pubitemid 8096326)
82. Insogna KL, Broadus AE, Dryer BE, Ellison AF, Gertner JM (1985) Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 61:490-495 (Pubitemid 15243961)
83. 3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 24:307-313
84. Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, Guadagno V, Strazzullo P, Nunziata V (2004) Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients. Urology 64:833-838 (Pubitemid 39446084)
85. Bid HK, Kumar A, Kapoor R, Mittal RD (2005) Association of vitamin D receptor gene (Fokl) polymorphism with calcium oxalate nephrolithiasis. J Endourol 19:111-115 (Pubitemid 40365756)
86. Chen WC, Chen HY, Lu HF, Hsu CD, Tsai FJ (2001) Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease. BJU Int 87:168-171 (Pubitemid 32142522)
87. Valdivielso JM, Fernandez E (2006) Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 371:1-12 (Pubitemid 44162891)
88. Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR, Jarrett TW (1999) Familial calcium stone disease: Taql polymorphism and the vitamin D receptor. J Endourol 13:313-316 (Pubitemid 29325601)
89. Favus MJ (1994) Hypercalciuria: lessons from studies of genetic hypercalciuric rats. J Am Soc Nephrol 5:S54-S58
90. Gambaro G, Vezzoli G, Casari G, Rampoldi L, D'Angelo A, Borghi L (2004) Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis 44:963-986 (Pubitemid 39556477)
91. Chattopadhyay N, Brown EM (2006) Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing. Mol Genet Metab 89:189-202 (Pubitemid 44442994)
92. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi ML (2002) Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 13:2517-2523
93. Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'Agruma L, Bertoldo F, Florio C, Minisola S, Hendy GN, Cole DEC (2004) Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab 89:5634-5638 (Pubitemid 39518452)
94. Parks JH, Coe FL (1996) Pathogenesis and treatment of calcium stones. Semin Nephrol 16:398-411 (Pubitemid 26320149)